Amanote Research
Register
Sign In
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients
Journal of Clinical Medicine
doi 10.3390/jcm8111791
Full Text
Open PDF
Abstract
Available in
full text
Date
October 25, 2019
Authors
Unknown
Publisher
MDPI AG
Related search
Validation of C-Reactive Protein Levels as a Prognostic Indicator for Survival in a Large Cohort of Pancreatic Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Prognostic Significance of C-Reactive Protein-To-Prealbumin Ratio in Patients With Esophageal Cancer
Yonago Acta Medica
Medicine
C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients With Resectable Esophageal Squamous Cell Carcinoma
Journal of Oncology
Oncology
The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients With Gastric Adenocarcinoma
Journal of Gastrointestinal Cancer
Oncology
Gastroenterology
Prognostic Factors in Metastatic Pancreatic Cancer: Older Patients Are Associated With Reduced Overall Survival
Molecular and Clinical Oncology
Cancer Research
Oncology
Development and Internal Validation of a Nine-lncRNA Prognostic Signature for Prediction of Overall Survival in Colorectal Cancer Patients
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
C-Reactive Protein to Albumin Ratio Is a Prognostic Factor for Patients With cStage II/III Esophageal Squamous Cell Cancer
Diseases of the Esophagus
Medicine
Gastroenterology
Serum C-Reactive Protein as Independent Prognostic Variable in Patients With Ovarian Cancer
Clinical Cancer Research
Cancer Research
Oncology
Clinical and Prognostic Implications of Pretreatment Albumin to C-Reactive Protein Ratio in Patients With Hepatocellular Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
